#NovoNordisk is facing #generics of its #GLP1 drug in India, #Atrogi is testing a new #weightloss approach, and there's new data on #Structure's lead drug.

pharmaphorum.com/news/generic...

Atrogi Starts Human Trial of Groundbreaking Muscle-Sparing Treatment ATR-258 Atrogi has initiated a human trial for ATR-258, an innovative oral therapy designed to mimic exercise effects for muscle health and fat loss.

Atrogi Starts Human Trial of Groundbreaking Muscle-Sparing Treatment ATR-258 #Sweden #Stockholm #Atrogi #ATR-258 #Morten_Hostrup

Atrogi's Innovative Study Unveils New Muscle Therapy for Metabolic Diseases Atrogi's breakthrough study reveals a novel muscle-targeted therapy, ATR-258, showcasing its efficacy in treating metabolic diseases like obesity and diabetes.

Atrogi's Innovative Study Unveils New Muscle Therapy for Metabolic Diseases #Sweden #Stockholm #Atrogi #ATR-258 #metabolic_therapy